Consolidated Balance Sheets (USD $)	Sep. 30, 2012	Dec. 31, 2011
Current Assets
Cash and cash equivalents	$ 5,390,611	$ 3,935,160
Accounts receivable trade, net of allowance for doubtful accounts of $442,302 and $187,600, respectively	1,794,579	1,010,475
Inventory	448,045	647,745
Prepaids and other current assets	3,228,775	649,739
Assets related to discontinued operations	37,024,245	32,367,217
Total current assets	47,886,255	38,610,336
Property, plant and equipment, net	11,067,570	11,616,053
Goodwill	11,117,770	11,117,770
Intangible assets, net	14,632,130	15,086,038
Other assets	932,474	3,326,938
Assets related to discontinued operations	43,169,861	75,570,645
Assets, Total	128,806,060	155,327,780
Current Liabilities
Accounts payable	2,570,879	2,287,201
Accrued liabilities	1,385,510	1,090,176
Notes payable	135,222	148,062
Mortgages payable	3,493,708	3,635,061
Unearned revenues	778,088	1,121,134
Other liabilities	2,728,000	0
Liabilities related to discontinued operations	39,343,867	28,165,010
Total current liabilities	50,435,274	36,446,644
Long-term Liabilities
Deferred income taxes	3,774,655	3,774,655
Unearned revenues	143,734	169,198
Notes payable	48,317	0
Derivative liabilities	427,553	474,463
Acquisition-related contingent consideration	3,130,000	3,130,000
Other long-term liabilities	139,276	0
Liabilities related to discontinued operations	14,279,651	26,388,976
Total long-term liabilities	21,943,186	33,937,292
Commitments and Contingencies
Redeemable Securities
Convertible Redeemable Series E Preferred Stock; 10,582,011 shares designated, liquidation value $1.00 per share; issued and outstanding 3,135,411 and 6,662,748 shares, at September 30, 2012 and December 31, 2011, respectively	2,721,132	4,811,326
Shareholders' Equity
Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 1 share of common stock, $.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at September 30, 2012 and December 31, 2011	100	100
Common stock, $.001 par value, authorized 500,000,000 shares; issued and outstanding, 155,141,086 and 109,329,587 shares, at September 30, 2012 and December 31, 2011, respectively	155,141	109,330
Additional paid-in capital	225,528,652	200,858,638
Accumulated deficit	(181,622,667)	(143,094,854)
Accumulated other comprehensive income	4,148,767	4,152,343
Total NeoStem, Inc. shareholders' equity	48,209,993	62,025,557
Noncontrolling interests	5,496,475	18,106,961
Total equity	53,706,468	80,132,518
Liabilities and Equity, Total	$ 128,806,060	$ 155,327,780